Group 1 - The pace of Henan enterprises planning to list in Hong Kong has significantly accelerated, with three companies advancing their listing processes within a week, marking an unusual frequency in the history of Henan's capital market [1] - Muyuan Foods has successfully passed the Hong Kong Stock Exchange listing hearing, positioning itself as the world's largest pig farming enterprise, while Hanwei Technology and Jinxing Beer have also announced their plans to list in Hong Kong [1] - Other Henan enterprises, such as Real Bio, Banu Hotpot, and United Information Technology, are also actively preparing for their Hong Kong listings, contributing to a growing trend of Henan companies seeking to enter the capital market [1] Group 2 - The recent surge in Hong Kong listings is driven by a resonance of policies, market conditions, and corporate needs, with the Henan government introducing a high-quality development action plan for the private economy and establishing a "green channel" for companies seeking to list [2] - Listing in Hong Kong not only injects capital into enterprises but also encourages them to enhance governance structures and management standards according to international norms, creating a dual empowerment effect in capital markets [2] - The concentration of Henan enterprises planning to list reflects the province's deeper integration into domestic and international dual circulation, showcasing a transformation of key variables into significant increments for high-quality development [2]

Group 1 - The pace of Henan enterprises planning to list in Hong Kong has significantly accelerated, with three companies advancing their listing processes within a week, which is rare in the history of Henan's capital market [1] - Muyuan Foods, the world's largest pig farming company, has successfully passed the Hong Kong Stock Exchange listing hearing, moving closer to its listing [1] - Hanwei Technology announced its plan to list in Hong Kong, aiming to leverage the platform for international expansion [1] - Jinxing Beer submitted its main board listing application to the Hong Kong Stock Exchange, marking the beginning of local beer companies' engagement with international capital markets [1] Group 2 - The recent wave of listings is driven by a synergy of policies, market conditions, and corporate needs, with the Henan government promoting high-quality development of the private economy and establishing a "green channel" for companies seeking to list [1] - Listing in Hong Kong not only injects capital into enterprises but also encourages them to improve governance structures and management standards according to international norms [2] - Leading companies are utilizing A-shares for high valuation financing while expanding international capital channels through Hong Kong listings, creating a dual empowerment effect in the capital market [2] - The recent surge in Henan enterprises planning to list reflects the province's deeper integration into domestic and international dual circulation, showcasing a transformation of key variables into significant growth for high-quality development [2]

Investment Rating - The industry rating is "Outperform the Market," indicating that the overall return of the industry is expected to exceed the market benchmark index by more than 5% in the next 6 months [6][13]. Core Insights - Merge Labs has successfully completed a seed round financing of approximately $250 million, achieving a valuation of $850 million. This financing was led by OpenAI, with its CEO Sam Altman participating as a co-founder and investor. Unlike mainstream brain-machine interface technologies, Merge Labs focuses on a non-invasive or minimally invasive approach centered on ultrasound, bypassing the traditional "electrode-neuron" paradigm [3][4]. - The brain-machine interface market is projected to grow rapidly, with the global market size expected to reach approximately $2.62 billion in 2024 and $2.94 billion in 2025, potentially growing to $12.4 billion by 2034, reflecting a compound annual growth rate (CAGR) of 17.35% over the next decade. In China, the market size is anticipated to be 3.2 billion yuan in 2024, increasing to 6.14 billion yuan by 2028 [5]. Summary by Sections Investment Highlights - Merge Labs' ultrasound-based technology aims to balance between non-invasive (safe but limited resolution) and invasive (clear signals but with surgical risks and ethical concerns) methods. The unique potential of ultrasound's deep penetration and "soft interface" concept is highlighted, although the technology is still in the laboratory research phase and faces multiple unresolved challenges [4]. Market Outlook - The report emphasizes the strategic importance of brain-machine interfaces as a key sector in the "14th Five-Year Plan," aiming to drive new economic growth points. The industry is expected to gain momentum over the next decade, potentially creating a new high-tech industry in China [5]. Recommended Companies - The report suggests monitoring companies such as Rock Mountain Technology, Hanwei Technology, Sanbo Brain Science, Innovation Medical, Dongfang Zhongke, Xiangyu Medical, Entropy Technology, Chengyitong, Weisi Medical, Meilan De, Aipeng Medical, and Beiyikang for potential investment opportunities [5].

Group 1 - The core viewpoint of the article highlights the increasing trend of Henan enterprises pursuing listings in Hong Kong, with companies like Muyuan Foods, Hanwei Technology, and Jinxing Beer announcing their latest progress in just one week [1][2][3] - The listing activities are driven by multiple factors including financing for expansion, brand upgrades, and governance optimization, marking a significant integration of the Central Plains economy with global capital [1][2] - Hanwei Technology plans to issue H-shares not exceeding 15% of its total share capital post-issue, with funds directed towards R&D, mergers and acquisitions, and production expansion [2][4] Group 2 - Jinxing Beer aims to become the "first Chinese craft beer" by enhancing production capacity, global sales channels, and brand marketing through its upcoming IPO [3][4] - The appeal of the Hong Kong stock market is bolstered by supportive policies, market advantages, and the development needs of enterprises, creating a conducive environment for listings [4][5] - The China Securities Regulatory Commission has introduced measures to facilitate the listing of mainland enterprises in Hong Kong, including streamlining the approval process and reducing costs [5][6] Group 3 - The global pig farming industry presents significant growth opportunities, and Muyuan Foods intends to leverage its technological advantages and cost control to capture overseas market potential [6] - The differentiation in listing paths for Henan enterprises reflects their specific development needs, with A-shares being more suitable for domestic-focused companies and Hong Kong listings appealing to those with international expansion plans [7][8] - The dual listing strategy ("A+H") allows leading enterprises to achieve high valuations in A-shares while expanding their international capital channels through Hong Kong [7][8]

汉威科技：拟在境外公开发行H股股票并在香港联合交易所有限公司上市。 ...

（草案） （H 股发行并上市后适用） 第一章 总 则 汉威科技集团股份有限公司 股东会议事规则 汉威科技集团股份有限公司 股东会议事规则 第一条 为提高汉威科技集团股份有限公司（以下简称"公司"或"本公司"） 的治理水平及工作效率，明确股东会的权责权限，保证股东会依法行使职权，规 范股东会的议事程序，维护股东的合法权益，根据《中华人民共和国公司法》（以 下简称《公司法》）、《中华人民共和国证券法》（以下简称《证券法》）、《深 圳证券交易所创业板股票上市规则》（以下简称《创业板上市规则》）、《上市 公司股东会规则》《深圳证券交易所上市公司自律监管指引第2号—创业板上市 公司规范运作》《上市公司治理准则》《香港联合交易所有限公司证券上市规则》 （以下简称《香港上市规则》等有关法律法规、规范性文件和《汉威科技集团股 份有限公司章程》（以下简称公司章程）的规定，制定本规则。 第二条 公司股东会的召集、提案、通知、召开等事项适用本规则。 公司应当严格按照法律、行政法规、公司股票上市地证券监管规则、本规 则及公司章程的相关规定召开股东会，保证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全 ...

汉威科技集团股份有限公司 董事会审计委员会工作制度 汉威科技集团股份有限公司 董事会审计委员会工作制度 （草案） （H 股发行并上市后适用） 第一章 总则 第一条 为强化董事会决策功能,做到事前审计、专业审计，确保董事会对经 理层的有效监督，完善公司治理结构，根据《中华人民共和国公司法》《上市公 司治理准则》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公 司自律监管指引第 2 号—创业板上市公司规范运作》《上市公司独立董事管理办 法》《香港联合交易所证券上市规则》（以下简称《香港上市规则》）等有关法 律、法规、规范性文件及《汉威科技集团股份有限公司章程》（以下简称"《公 司章程》"）的规定，公司特设立董事会审计委员会，并制定本工作制度。 第二条 董事会审计委员会是董事会下设的专门工作机构，行使《公司法》 规定的监事会的职权及公司股票上市地证券监管规则规定的职权，主要负责审核 公司财务信息及其披露、监督及评估内外部审计工作和内部控制。 公司应当为审计委员会提供必要的工作条件，配备专门人员或者机构承担审 计委员会的工作联络、会议组织、材料准备和档案管理等日常工作。审计委员会 履行职责时，公司管理层及相 ...

汉威科技集团股份有限公司 关联（连）交易控制与交易制度 （草案） （H股发行并上市后适用） 第一章 总则 汉威科技集团股份有限公司 关联交易控制与交易制度 第一条 为规范汉威科技集团股份有限公司(以下简称"公司")的关联（连）交易管理， 明确管理职责和分工，保证公司与关联（连）方之间订立的关联（连）交易合同符合公平、公 正的原则，保护广大投资者特别是中小投资者的合法权益，根据《中华人民共和国公司法》《中 华人民共和国证券法》《深圳证券交易所创业板股票上市规则》（以下简称"《创业板上市规 则》"）、《深圳证券交易所上市公司自律监管指引第 7 号——交易与关联交易》、《香港联 合交易所有限公司证券上市规则》（以下简称"《香港上市规则》"）及《证券及期货条例》 （香港法例第571 章)等有关法律、法规、规范性文件及《汉威科技集团股份有限公司章程》 （以下简称"《公司章程》"）的有关规定，制订本制度。 第二章 关联（连）人 第二条 公司关联（连）人包括符合《创业板上市规则》定义的关联法人和关联自然人， 以及符合《香港上市规则》定义的关连人士。 第三条 根据《创业板上市规则》，具有以下情形之一的法人或者其他组织，为公司 ...

汉威科技集团股份有限公司 境外发行证券及上市相关的保密和档案管理制度 汉威科技集团股份有限公司 境外发行证券及上市相关的保密和档案管理制度 第一条 为保障国家经济安全，保护社会公共利益及汉威科技集团股份有 限公司（以下简称"公司"）的利益，维护公司在中华人民共和国（以下简称 "中国"）境外发行证券及上市过程中的信息安全，规范公司及各证券服务机 构在公司境外发行证券及上市过程中的档案管理，根据《中华人民共和国证券 法》《中华人民共和国保守国家秘密法》《中华人民共和国档案法》《中华人 民共和国国家安全法》《境内企业境外发行证券和上市管理试行办法》《关于 加强境内企业境外发行证券和上市相关保密和档案管理工作的规定》等有关法 律、法规、规范性文件的规定及《汉威科技集团股份有限公司章程》（以下简 称"《公司章程》"），以及《香港联合交易所有限公司证券上市规则》等公 司股票上市地证券监管规则的有关规定，结合公司情况，制定本制度。 第二条 本制度所称"境外发行证券及上市"，是指公司在中国大陆地区 以外的国家或地区发行证券及上市。本制度适用于公司境外发行证券及上市的 全过程，包括申请阶段、备案阶段、审核阶段及上市阶段。 第三 ...

汉威科技集团股份有限公司公司章程 汉威科技集团股份有限公司 （H 股发行并上市后适用） 2026 年 1 月 1 | 第一章 | 总则 | 4 | | | --- | --- | --- | --- | | 第二章 | 经营宗旨和范围 | 5 | | | 第三章 | 股 份 | 6 | | | 第一节 | 股份发行 | 6 | | | 第二节 | | 股份增减和回购 | 8 | | 第三节 | 股份转让 | 9 | | | 第四章 | 股东和股东会 | | 10 | | 第一节 | 股东 | | 10 | | 第二节 | | 控股股东和实际控制人 13 | | | 第三节 | | 股东会的一般规定 | 14 | | 第四节 | | 股东会的召集 | 17 | | 第五节 | | 股东会的提案与通知 18 | | | 第六节 | | 股东会的召开 | 20 | | 第七节 | | 股东会的表决和决议 23 | | | 第五章 | 董事会 | 27 | | | 第一节 | 董事 | | 27 | | 第二节 | | 董事会 30 | | | 第三节 | 独立董事 | 35 | | | 第四节 | | 董事会专门委 ...